Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001102624-14-001281
Filing Date
2014-08-08
Accepted
2014-08-08 10:39:06
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 BOSTON THERAPEUTICS, INC. 10-Q bostonthera10q.htm 10-Q 534927
2 EXHIBIT 10.1 exh10_1.htm EX-10.1 72425
3 EXHIBIT 31.1 exh31_1.htm EX-31.1 18278
4 EXHIBIT 31.2 exh31_2.htm EX-31.2 18410
5 EXHIBIT 32.1 exh32_1.htm EX-32.1 7845
6 EXHIBIT 32.2 exh32_2.htm EX-32.2 7427
  Complete submission text file 0001102624-14-001281.txt   2677639

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bthe-20140630.xml EX-101.INS 271852
8 XBRL TAXONOMY EXTENSION SCHEMA bthe-20140630.xsd EX-101.SCH 26004
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bthe-20140630_cal.xml EX-101.CAL 31189
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bthe-20140630_def.xml EX-101.DEF 31236
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bthe-20140630_lab.xml EX-101.LAB 193693
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bthe-20140630_pre.xml EX-101.PRE 126100
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54586 | Film No.: 141026019
SIC: 2834 Pharmaceutical Preparations